leisure time -WSS

leisure time

author：Wikipedia 2025-09-29 23:12:36 - browse：49

Stain of a biopsy specimen of a rhabdoid tumor -- health coverage from STAT — Stain of a biopsy specimen of a rhabdoid tumor. Wikimedia Commons

Most targeted cancer drugs work like tranquilizer darts, snaring an overzealous gene that has spurred the cell into murderously rapid growth.

But many tumors don’t have a hyperactive gene. Like the mayhem in “Cat in the Hat,” they are enabled by parental absence. They grow because the genes that are meant to provide discipline, guiding the activity of other genes or self-destructing a cell whose DNA is too damaged, are broken or missing.

These tumors have bedeviled researchers for decades. Restoring or fixing a protein is far harder than breaking it. And that’s bad news for humanity: Cancer is far more likely to be caused by such “tumor-suppressor” genes than by one gene run amok.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： J&J expands global access to TB drug amid advocacy campaign

WSS

Congenital heart disease patients face new threat of heart failure

Congress likely to miss an opportunity to fix drug shortages issue

Pregnancy discrimination could be enabled by AI

Leukemia patients are helped by Syndax's new type of therapy

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Woman gored by Bison at Yellowstone

knowledge

leisure time

leisure time

What does generative AI mean for health care? We asked experts

After sickle

Supreme Court strikes down use of affirmative action

Leukemia patients are helped by Syndax's new type of therapy

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Congress likely to miss an opportunity to fix drug shortages issue

Continuity nursing helped my family in our darkest PICU moments

Spinal cord stimulation reduces pain in amputees, study finds

BioMarin wins approval for gene therapy to treat hemophilia A

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

focus

Georgia court denies Trump's request to quash DA's 2020 election probe

Can CDC director Mandy Cohen drive consensus in Washington?

Patients' immediate access to test results puts radiologists in a bind

What causes an itch? Researchers may have solved the mystery

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Grail faces three suits alleging harassment, retaliation

focus

explore

focus

Wikipedia